Lonza officials have said they plan to be aggressive in bringing customers' new drugs into the massive, 750-person facility. Contract drug developer and manufacturer Lonza AG wrapped up its $1.2 ...
A $1.2 billion deal by Swiss biotech firm Lonza to purchase the Vacaville Genentech site from Roche has been finalized, the firm announced Tuesday, securing 750 biotech jobs in Vacaville.
Image shows Roche’s head office in California, USA. Credit: Michael Vi via Shutterstock. Genentech is strengthening its oncology pipeline by acquiring Regor Pharmaceuticals’ portfolio of breast cancer ...
Genentech, a subsidiary of Roche, has laid down $850m for Regor Pharmaceuticals’ portfolio of next-generation CDK inhibitors for the treatment of breast cancer. The deal positions Genentech to lead ...
With rare exceptions, biotechnology and pharmaceutical companies validate their business plans through clinical trials, results from which are often presented and dissected at medical conferences ...
Genentech is paying $850 million upfront for Regor Pharmaceuticals’ portfolio of CDK inhibitors, taking ownership of a breast cancer candidate that has shown signs of single-agent efficacy in ...
(RTTNews) - Regor Pharmaceuticals USA has entered into a definitive purchase agreement, under which Genentech, a member of the Roche Group, will acquire a portfolio of next-generation CDK ...
Ultimate Personas are a beautiful way to demonstrate character growth, and Persona 3 and the Reload remake's approach is a model P6 could lean on.
You’ve reached your account maximum for followed topics. Monopoly GO spices things up by introducing a new Sticker Album every few months, giving players a fresh set of collectibles to chase and ...
Genentech plans to expand the label for its CD20-targeting antibody Gazyva following positive late-stage data in an autoimmune disease that impacts the kidneys.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback